What are the major opportunities in the Patient Risk Stratification market? What are the strategies for the Patient Risk Stratification market?

For detailed insights on the major opportunities and strategies in the Patient Risk Stratification market, Read More

How does the Patient Risk Stratification market relate to the overall economy and other similar markets?

For detailed insights on Patient Risk Stratification's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Patient Risk Stratification market growth? SWOT analysis of the Patient Risk Stratification market.

For detailed insights on the key dynamics influencing the Patient Risk Stratification market growth and SWOT analysis of the Patient Risk Stratification industry, Read More

Global Patient Risk Stratification Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Patient Risk Stratification Global Market Report 2025

Name: Patient Risk Stratification Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model), By Component (Software, Services), By Delivery Model (On-Premise, Cloud-Based), By Application (Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications), By End User (Healthcare Providers, Healthcare Payers, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Patient Risk Stratification Market Overview

• Patient Risk Stratification market size has reached to $2.15 billion in 2024

• Expected to grow to $8.2 billion in 2029 at a compound annual growth rate (CAGR) of 30.7%

• Growth Driver: Impact Of Rising Chronic Disease Burden On The Growth Of The Patient Risk Stratification Market

• Market Trend: Technological Advancements In AI-Driven Disease Screening For Enhancing Patient Risk Stratification And Care

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Patient Risk Stratification Market?

Patient risk stratification is the process of assessing and categorizing patients based on their risk of experiencing adverse health outcomes. It is used to identify high-risk patients for targeted interventions, optimize resource allocation, facilitate preventive care, improve care coordination, enhance patient outcomes, reduce costs, and support population health management.

The main types of patient risk stratification are predictive risk stratification models, retrospective risk stratification models, prospective risk stratification models, and concurrent risk stratification models. Predictive risk stratification models use historical and current patient data to forecast future health outcomes and identify individuals at high risk of developing specific conditions or complications. The components are software and services, and the delivery models include on-premise and cloud-based. The various applications are risk adjustment, clinical workflow, revenue cycle management, and others, and they are used by various end users such as healthcare providers, healthcare payers, and others.

Patient Risk Stratification Market Size and growth rate 2025 to 2029: Graph

What Is The Patient Risk Stratification Market Size 2025 And Growth Rate?

What Is The Patient Risk Stratification Market Growth Forecast?

The patient risk stratification market size is expected to see exponential growth in the next few years. It will grow to $8.2 billion in 2029 at a compound annual growth rate (CAGR) of 30.7%. The growth in the forecast period can be attributed to rising middle-class and health insurance, increasing prevalence of chronic diseases, growing adoption of predictive analytics, growing emphasis on social determinants of health (SDOH), and expanding use of technology. Major trends in the forecast period include advancements in analytics, artificial intelligence (AI), machine learning, technological advancements, innovative tools, technological advancements in healthcare, wearable technology, and remote monitoring.

The forecast of 30.7% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. providers by driving up the cost of predictive analytics tools sourced from Israel and Germany, exacerbating value-based care expenses and limiting early intervention capabilities. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Patient Risk Stratification Market Segmented?

1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model

2) By Component: Software, Services

3) By Delivery Model: On-Premise, Cloud-Based

4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications

5) By End User: Healthcare Providers, Healthcare Payers, Other End Users

Subsegments:

1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models

2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models

3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models

4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models

What Is Driving The Patient Risk Stratification Market? Impact Of Rising Chronic Disease Burden On The Growth Of The Patient Risk Stratification Market

The growing burden of chronic diseases is expected to propel the growth of the patient risk stratification market going forward. Chronic diseases are long-lasting health conditions that persist for extended periods, typically three months or longer. The growing burden of chronic diseases can be attributed to an aging population, unhealthy lifestyles, urbanization, environmental factors, limited healthcare access, economic disparities, and increased stress levels. Patient risk stratification helps identify individuals at different risk levels for chronic diseases, allowing for personalized care, early intervention, better resource allocation, and improved health outcomes. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the number of individuals aged 50 and older with at least one chronic illness is projected to increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Furthermore, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, chronic diseases accounted for 74% of all deaths globally, with 41 million deaths annually. Cardiovascular diseases cause 17.9 million deaths, cancer causes 9.3 million, chronic respiratory diseases cause 4.1 million, and diabetes causes 2.0 million deaths. Therefore, the growing burden of chronic diseases drives the patient risk stratification industry.

Who Are The Major Players In The Global Patient Risk Stratification Market?

Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation

What Are The Key Trends Of The Global Patient Risk Stratification Market? Technological Advancements In AI-Driven Disease Screening For Enhancing Patient Risk Stratification And Care

Major companies operating in the patient risk stratification market are focusing on technological advancements in healthcare, such as artificial intelligence (AI) in disease screening, to improve early detection, enhance patient outcomes, and reduce healthcare costs by enabling more accurate risk assessments and personalized treatment plans. AI in disease screening utilizes sophisticated algorithms and machine learning to examine medical data, enabling early disease detection and improving diagnostic accuracy by quickly analyzing large amounts of information. For instance, in May 2024, WELL Health Technologies Corporation, a Canada-based healthcare company, and its investee company HEALWELL AI, a Canada-based healthcare company focused on AI and data science for preventative care, launched WELL AI Decision Support (WAIDS). It is aimed at rare diseases and now includes screening for chronic conditions such as kidney disease, hypertension, and diabetes. It can detect over 100 diseases and provide risk stratification, helping clinicians identify care gaps and access actionable data at the point of care.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Patient Risk Stratification Market? Acquisition To Enhance Patient Outcomes And Healthcare Efficiency

In December 2023, Healthcare Outcomes Performance Company (HOPCo), a US-based provider of healthcare performance improvement solutions focusing on data analytics and patient outcomes, acquired MyACTome for an undisclosed amount. With this acquisition, HOPCo aims to improve patient outcomes and enhance the efficiency of healthcare delivery. MyACTome is a US-based company smartphone-based platform that specializes in assessing fall risk and frailty, playing a crucial role in patient risk stratification.

What Is The Regional Outlook For The Global Patient Risk Stratification Market?

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Patient Risk Stratification Market?

The patient risk stratification market includes revenues earned by entities by risk assessment and stratification services, telehealth services, medication management services, chronic disease risk assessment services, and genomic risk stratification services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Patient Risk Stratification Industry?

The patient risk stratification market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the patient risk stratification industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Patient Risk Stratification Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.81 billion
Revenue Forecast In 2034	$8.2 billion
Growth Rate	CAGR of 30.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The patient risk stratification market covered in this report is segmented – 1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model 2) By Component: Software, Services 3) By Delivery Model: On-Premise, Cloud-Based 4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications 5) By End User: Healthcare Providers, Healthcare Payers, Other End Users Subsegments: 1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models 2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models 3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models 4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Patient Risk Stratification Market Characteristics

3. Patient Risk Stratification Market Trends And Strategies

4. Patient Risk Stratification Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Patient Risk Stratification Growth Analysis And Strategic Analysis Framework

5.1. Global Patient Risk Stratification PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Patient Risk Stratification Market Growth Rate Analysis

5.4. Global Patient Risk Stratification Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Patient Risk Stratification Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Patient Risk Stratification Total Addressable Market (TAM)

6. Patient Risk Stratification Market Segmentation

6.1. Global Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Predictive Risk Stratification Model

Retrospective Risk Stratification Model

Prospective Risk Stratification Model

Concurrent Risk Stratification Model

6.2. Global Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software

Services

6.3. Global Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

On-Premise

Cloud-Based

6.4. Global Patient Risk Stratification Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Risk Adjustment

Clinical Workflow

Revenue Cycle Management

Other Applications

6.5. Global Patient Risk Stratification Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Healthcare Providers

Healthcare Payers

Other End Users

6.6. Global Patient Risk Stratification Market, Sub-Segmentation Of Predictive Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Machine Learning-Based Predictive Models

Statistical Predictive Models

AI-Powered Predictive Models

6.7. Global Patient Risk Stratification Market, Sub-Segmentation Of Retrospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Historical Data-Based Risk Models

Data Mining Retrospective Models

6.8. Global Patient Risk Stratification Market, Sub-Segmentation Of Prospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Longitudinal Cohort-Based Models

Real-Time Risk Assessment Models

6.9. Global Patient Risk Stratification Market, Sub-Segmentation Of Concurrent Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In-Hospital Risk Assessment Models

Real-Time Clinical Decision Support Models

7. Patient Risk Stratification Market Regional And Country Analysis

7.1. Global Patient Risk Stratification Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Patient Risk Stratification Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Patient Risk Stratification Market

8.1. Asia-Pacific Patient Risk Stratification Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Patient Risk Stratification Market

9.1. China Patient Risk Stratification Market Overview

9.2. China Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Patient Risk Stratification Market

10.1. India Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Patient Risk Stratification Market

11.1. Japan Patient Risk Stratification Market Overview

11.2. Japan Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Patient Risk Stratification Market

12.1. Australia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Patient Risk Stratification Market

13.1. Indonesia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Patient Risk Stratification Market

14.1. South Korea Patient Risk Stratification Market Overview

14.2. South Korea Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Patient Risk Stratification Market

15.1. Western Europe Patient Risk Stratification Market Overview

15.2. Western Europe Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Patient Risk Stratification Market

16.1. UK Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Patient Risk Stratification Market

17.1. Germany Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Patient Risk Stratification Market

18.1. France Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Patient Risk Stratification Market

19.1. Italy Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Patient Risk Stratification Market

20.1. Spain Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Patient Risk Stratification Market

21.1. Eastern Europe Patient Risk Stratification Market Overview

21.2. Eastern Europe Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Patient Risk Stratification Market

22.1. Russia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Patient Risk Stratification Market

23.1. North America Patient Risk Stratification Market Overview

23.2. North America Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Patient Risk Stratification Market

24.1. USA Patient Risk Stratification Market Overview

24.2. USA Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Patient Risk Stratification Market

25.1. Canada Patient Risk Stratification Market Overview

25.2. Canada Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Patient Risk Stratification Market

26.1. South America Patient Risk Stratification Market Overview

26.2. South America Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Patient Risk Stratification Market

27.1. Brazil Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Patient Risk Stratification Market

28.1. Middle East Patient Risk Stratification Market Overview

28.2. Middle East Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Patient Risk Stratification Market

29.1. Africa Patient Risk Stratification Market Overview

29.2. Africa Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Patient Risk Stratification Market Competitive Landscape And Company Profiles

30.1. Patient Risk Stratification Market Competitive Landscape

30.2. Patient Risk Stratification Market Company Profiles

30.2.1. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sales Force Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Patient Risk Stratification Market Other Major And Innovative Companies

31.1. Siemens Healthineers AG

31.2. Koninklijke Philips N.V.

31.3. GE HealthCare Technologies Inc.

31.4. Adobe Inc.

31.5. Persistent Systems

31.6. NextGen Healthcare Inc.

31.7. Health Catalyst

31.8. Freenome

31.9. Strive Health

31.10. Medeanalytics Inc.

31.11. American Academy of Family Physicians

31.12. Lightbeam Health Solutions

31.13. Graphnet Health Ltd.

31.14. Innova Medical Group Inc.

31.15. Equipo Health Inc.

32. Global Patient Risk Stratification Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Patient Risk Stratification Market

34. Recent Developments In The Patient Risk Stratification Market

35. Patient Risk Stratification Market High Potential Countries, Segments and Strategies

35.1 Patient Risk Stratification Market In 2029 - Countries Offering Most New Opportunities

35.2 Patient Risk Stratification Market In 2029 - Segments Offering Most New Opportunities

35.3 Patient Risk Stratification Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Patient Risk Stratification Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Patient Risk Stratification Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Patient Risk Stratification Market, Sub-Segmentation Of Predictive Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Patient Risk Stratification Market, Sub-Segmentation Of Retrospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Patient Risk Stratification Market, Sub-Segmentation Of Prospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Patient Risk Stratification Market, Sub-Segmentation Of Concurrent Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Patient Risk Stratification Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Patient Risk Stratification Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Bristol-Myers Squibb Financial Performance

Table 81: Thermo Fisher Scientific Inc. Financial Performance

Table 82: Abbott Laboratories Financial Performance

Table 83: Sales Force Inc. Financial Performance

Table 84: Medtronic plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Patient Risk Stratification Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Patient Risk Stratification Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Patient Risk Stratification Market, Sub-Segmentation Of Predictive Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Patient Risk Stratification Market, Sub-Segmentation Of Retrospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Patient Risk Stratification Market, Sub-Segmentation Of Prospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Patient Risk Stratification Market, Sub-Segmentation Of Concurrent Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Patient Risk Stratification Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Patient Risk Stratification Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Bristol-Myers Squibb Financial Performance

Figure 81: Thermo Fisher Scientific Inc. Financial Performance

Figure 82: Abbott Laboratories Financial Performance

Figure 83: Sales Force Inc. Financial Performance

Figure 84: Medtronic plc Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Health And Medical Insurance Global Market Report 2021 - By Type (Hospitalization Insurance, Hospital Daily Cash Benefit Insurance, Critical Illness Insurance, Domiciliary Insurance), By Service Provider (Private, Public...

Hospitalization Insurance Global Market Report 2025 – By Service Provider (Private, Public), By Network (Preferred Provider Organizations (PPOs), Point Of Service (POS), Health Maintenance Organizations (HMOs), Exclusive...

Patient Safety And Risk Management Software Global Market Report 2025 – By Type (Risk Management And Safety Solutions, Claims Management Solutions, Governance, Risk And Compliance Solutions), By Deployment Mode (Private ...

Patient Simulators Global Market Report 2025 – By Type (Childbirth Simulator, Adult Patient Simulator, Infant Simulator, Other Types), By Intensity (High-Fidelity Simulator, Medium-Fidelity Simulator, Low-Fidelity Simula...

Risk Management Global Market Report 2025 – By Component (Solution, Services, Professional, Managed), By Deployment Mode (Cloud-based, On-premises), By Vertical (Banking, Financial Services and Insurance (BFSI), Informat...

Healthcare Fraud Analytics Global Market Report 2025 – By Solution Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics), By Delivery Model (On-Premise, On-Demand), By Application (Insurance Claims R...

Medical Tourism Global Market Report 2025 – By Treatment Type (Cosmetic Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedics Treatment, Cancer Treatment, Fertility Treatment, Neurological Treatment, Other T...

Frequently Asked Questions

What is the definition of the Patient Risk Stratification market?

How will the Patient Risk Stratification market drivers and restraints affect the market dynamics? What forces will shape the Patient Risk Stratification industry going forward?

The market major growth driver - Impact Of Rising Chronic Disease Burden On The Growth Of The Patient Risk Stratification Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Patient Risk Stratification market?

The patient risk stratification market size has grown exponentially in recent years. It will grow from $2.15 billion in 2024 to $2.81 billion in 2025 at a compound annual growth rate (CAGR) of 30.9%. The growth in the historic period can be attributed to increased adoption of digitization, increased risk, rising geriatric population, rising frequency of medical errors, and rising adoption of electronic health records (EHR). The patient risk stratification market size is expected to see exponential growth in the next few years. It will grow to " $8.2 billion in 2029 at a compound annual growth rate (CAGR) of 30.7%. The growth in the forecast period can be attributed to rising middle-class and health insurance, increasing prevalence of chronic diseases, growing adoption of predictive analytics, growing emphasis on social determinants of health (SDOH), and expanding use of technology. Major trends in the forecast period include advancements in analytics, artificial intelligence (AI), machine learning, technological advancements, innovative tools, technological advancements in healthcare, wearable technology, and remote monitoring. For further insights on this market, request a sample here

How is the Patient Risk Stratification market segmented?

The patient risk stratificationmarket covered in this report is segmented –
1) By Type: Predictive Risk Stratification Model; Retrospective Risk Stratification Model; Prospective Risk Stratification Model; Concurrent Risk Stratification Model
2) By Component: Software; Services
3) By Delivery Model: On-Premise; Cloud-Based
4) By Application: Risk Adjustment; Clinical Workflow; Revenue Cycle Management; Other Applications
5) By End User: Healthcare Providers; Healthcare Payers; Other End Users Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models; Statistical Predictive Models; AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models; Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models; Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models; Real-Time Clinical Decision Support Models For further insights on this market, request a sample here

Which region has the largest share of the Patient Risk Stratification market? What are the other regions covered in the report?

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Patient Risk Stratification market?

What are the key trends in the Patient Risk Stratification market?

Major trends in this market include Technological Advancements In AI-Driven Disease Screening For Enhancing Patient Risk Stratification And Care. For further insights on this market, request a sample here.